Park and Grivas Expand on Treatment Updates in Bladder Cancer

Season 10 Episode 50  ·  Aug 07, 2024, 08:25 PM

Headliner
Share
Subscribe

Drs Park and Grivas discuss bladder cancer treatment updates, including results from the SunRISe-1 trial of TAR-200 plus cetrelimab in NMIBC.

Share
Subscribe
Next
Rotow Reviews Key Updates on the Management of CNS Metastases in NSCLC
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air